Lonza - Capsugel®
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

25

Feb 2020

Clover and GSK Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with Pandemic Adjuvant System

Clover Biopharmaceuticals a China based global clinicalstage biotechnology company focused on developing novel and transformative biologic therapies announced today that it has entered into a research collaboration with GSK for its proteinbased coronavirus vaccine candidate COVID STrimer GSK will pr...

24

Feb 2020

Aradigm Announces Entering into an Asset Purchase Agreement with Grifols, S.A.

Aradigm Corporation announced that the Company has entered into an Asset Purchase Agreement pursuant to which Grifols SA the Buyer will acquire the Companys assets and intellectual property that pertain to Lipoquin Free Ciprofloxacin Apulmiq and any derivatives thereof

21

Feb 2020

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

Hummingbird Bioscience an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficulttotreat conditions today announced it has signed an agreement with Mycenax Biotech for the production of material for the Phase clinical trial of its HMBD pro...

21

Feb 2020

Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies

Immatics Biotechnologies GmbH a clinicalstage biopharmaceutical company active in the discovery and development of Tcell redirecting cancer immunotherapies today announced it has entered into a strategic collaboration agreement with GSK to develop novel adoptive cell therapies targeting multiple can...

20

Feb 2020

Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs

Five Prime Therapeutics Inc a clinicalstage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers today announced a global license agreement with Seattle Genetics Inc to develop and commercialize novel antibodydrug conjugate ADC therapies using...

20

Feb 2020

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

Nimble Therapeutics Inc announced a multiyear collaboration with Genentech a member of the Roche Group to accelerate discovery and development of novel peptidebased medicines for targets across a range of diseases

19

Feb 2020

M8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil

M Pharmaceuticals and Vectans Pharma announced they have signed an exclusive licensing agreement whereby m will have the rights to register and commercialize Loramyc miconazole for Mexico and Brazil Loramyc is an antifungal agent administered as a mucoadhesive buccal tablet for the treatment of orop...

press releasesRead more...

25

Feb 2020

ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services

ProBioGen AG today announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics ProBioGen will support ImmunOs in the development of their biologics using its recently launched DirectedLuck Transposase technology and conducti...

25

Feb 2020

Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad, a Treatment for Hyperuricemia and Gout, in China

Eisai Co Ltd and FUJI YAKUHIN CO LTD announced today that they have concluded a license agreement concerning dotinurad generic name a treatment for hyperuricemia and gout discovered by FUJI YAKUHIN for development and distribution in China

25

Feb 2020

Turkish Cargo continued its steady growth in 2019

According to the international air cargo information provider WACDs Decemberdata cumulative the global air cargo brand Turkish Cargo which serves countries of the world grew significantly by achieving a tonnage increase of percent in a sector wherein the global air cargo market shrank by percent

25

Feb 2020

Perrigo and Catalent Announce FDA Approval of Perrigo's AB-rated Generic Version of ProAir® HFA

Perrigo Company plc and its partner Catalent Pharma Solutions announced that the US Food and Drug Administration FDA has approved Perrigos abbreviated new drug application for generic albuterol sulfate inhalation aerosol the first ABrated generic version of ProAir HFA Perrigo is launching a limited...

24

Feb 2020

Eminence Business Media presents the maiden “Pharma GMP, GCP & Quality Management 2020” on April 16th& 17th, 2020 at Hotel Westin Mumbai Garden City

The summit is bringing together the senior practitioners across the pharmaceutical industry to discover the best strategies approaches in order to remain competitive while meeting the industrys everevolving quality standards

24

Feb 2020

Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms

Sartorius a leading international partner of the biopharmaceutical industry today introduced BioPAT Spectro a Quality by Design QbD tool for use with its ambr automated micro and mini bioreactor systems and with the singleuse production bioreactors BIOSTAT STR The new tool offers access to Raman spe...

EventsRead more...

25 - 27

Feb 2020

DUPHAT 2020

Dubai International Convention Centre

25 - 27

Feb 2020

25 - 27

Feb 2020

RAS- Targeted Drug Discovery Europe Summit

Hanson Wade
Hilton Vienna Plaza

25 - 27

Feb 2020

Dubai international Pharmaceutical & Technology

Index Conferences & Exhibitions
Dubai international Convention and Exhibition center

26 - 28

Feb 2020

26 - 27

Feb 2020

21st Pharmacovigilance 2020

Pestana Chelsea Bridge Hotel

26 - 27

Feb 2020

Reduce Costs for Compliance with Data Integrity

Courtyard by Marriott Scottsdale Salt River

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    Treatment of Cancer Using Combined Chemo-Photo Approach

    Cancer is one of the leading causes of death in both developed and developing countries and also a major public health problem This dreadful disease is spreading with continuance and increasing incidences in recent times In million cancer patients died as per the reports of World Health Organization WHO which also estimated the increase in annual cancer cases

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...